Clinical Care of Renal Transplant Recipients: An Internist`s Guide
... *Adjusted for baseline age, sex, income, education, coronary disease, chronic heart failure, stroke or transient ischemic attack, peripheral artery disease, diabetes, hypertension, dyslipidemia, cancer, hypoalbuminemia, dementia, liver disease, proteinuria, prior hospitalizations, and subsequent dia ...
... *Adjusted for baseline age, sex, income, education, coronary disease, chronic heart failure, stroke or transient ischemic attack, peripheral artery disease, diabetes, hypertension, dyslipidemia, cancer, hypoalbuminemia, dementia, liver disease, proteinuria, prior hospitalizations, and subsequent dia ...
ALS
... pathology. For example, Progressive Muscular Atrophy (PMA) is a LMN syndrome without UMN signs. The “flail arm” and “flail leg” variants which are mostly LMN syndrome have wasting and weakness symmetrically either in upper or lower extremity. Also, Primary Lateral Sclerosis (PLS) is a purely progres ...
... pathology. For example, Progressive Muscular Atrophy (PMA) is a LMN syndrome without UMN signs. The “flail arm” and “flail leg” variants which are mostly LMN syndrome have wasting and weakness symmetrically either in upper or lower extremity. Also, Primary Lateral Sclerosis (PLS) is a purely progres ...
present there are no laboratory strat- egies to
... were performed in view of the seizures. We analyzed the extracted RNA from the CSF and serum samples of the patient by real-time quantitative RT-PCR assay targeting the polymerase region (orf1ab polyprotein) of the SARS-CoV genome (3 ). Our data showed that SARS-CoV RNA was present in both the CSF a ...
... were performed in view of the seizures. We analyzed the extracted RNA from the CSF and serum samples of the patient by real-time quantitative RT-PCR assay targeting the polymerase region (orf1ab polyprotein) of the SARS-CoV genome (3 ). Our data showed that SARS-CoV RNA was present in both the CSF a ...
RYTARY (carbidopa and levodopa) TASMAR (tolcapone) ZELAPAR
... individual generic components. When the drug in question is a low dose formulation, there must be documentation of failure / ineffectiveness of low dose generic formulation. Adverse Drug Event: Allergic reaction / Hypersensitivity / Intolerance Use of a drug produced a significant reaction where con ...
... individual generic components. When the drug in question is a low dose formulation, there must be documentation of failure / ineffectiveness of low dose generic formulation. Adverse Drug Event: Allergic reaction / Hypersensitivity / Intolerance Use of a drug produced a significant reaction where con ...
Chemotherapy Order Assessment and Review
... suggested maximum lifetime dose due to toxicities associated with accumulated doses. In the case of bleomycin, pulmonary toxicity may be exhibited by the onset of symptoms such as a dry hacking cough, shortness of breath, fever, and fatigue. These can occur during active bleomycin therapy or after t ...
... suggested maximum lifetime dose due to toxicities associated with accumulated doses. In the case of bleomycin, pulmonary toxicity may be exhibited by the onset of symptoms such as a dry hacking cough, shortness of breath, fever, and fatigue. These can occur during active bleomycin therapy or after t ...
Advances in the Management of Treatment- Resistant Depression
... failed treatments (see above for details). T3 augmentation was associated with a 25% remission rate and a 23% response rate (response was defined using a different scale than that used to define remission; in addition, it is possible that some patients achieved remission without having a 50% decreas ...
... failed treatments (see above for details). T3 augmentation was associated with a 25% remission rate and a 23% response rate (response was defined using a different scale than that used to define remission; in addition, it is possible that some patients achieved remission without having a 50% decreas ...
Analyses and Displays Associated with Demographics
... and analysis datasets (ADaM). There is now recognition that the next step would be to develop standard TFLs for common measurements across clinical trials and across therapeutic areas. Some could argue that perhaps the industry should have started with creating standard TFLs prior to creating standa ...
... and analysis datasets (ADaM). There is now recognition that the next step would be to develop standard TFLs for common measurements across clinical trials and across therapeutic areas. Some could argue that perhaps the industry should have started with creating standard TFLs prior to creating standa ...
Unstable Angina
... found in 10–15% of patients with unstable angina. A subset of patients (5–10%) with angiographically normal or near normal coronary arteries may have noncardiac symptoms masquerading as unstable angina, the clinical syndrome X (ischemic symptoms with angiographically normal arteries and possible mi ...
... found in 10–15% of patients with unstable angina. A subset of patients (5–10%) with angiographically normal or near normal coronary arteries may have noncardiac symptoms masquerading as unstable angina, the clinical syndrome X (ischemic symptoms with angiographically normal arteries and possible mi ...
EPREX 2 000 IU/0,5 ml
... haematologic diseases (e.g. haemolytic anaemia, sickle cell anaemia, thalassemia, porphyria). ...
... haematologic diseases (e.g. haemolytic anaemia, sickle cell anaemia, thalassemia, porphyria). ...
reverse ball and socket arthroplasty protocol
... considered using an empirical regbe vigorously treated as any other imen (Table 3). In addition, antibipatient with elimination of the otic prophylaxis may be considered source of the infection (incision and drainage, when the higher-risk dental procedures (again, as endodontics, extraction) and app ...
... considered using an empirical regbe vigorously treated as any other imen (Table 3). In addition, antibipatient with elimination of the otic prophylaxis may be considered source of the infection (incision and drainage, when the higher-risk dental procedures (again, as endodontics, extraction) and app ...
+ Safety aspects and rational use of a naproxen of rheumatoid disease
... NSAID usage occurs in 11% of the US population, which increases the odds of gastrointestinal bleeding five- to six-fold compared with those not taking NSAIDs.15,16 Some 1%–4% of NSAID users have serious ulcer-related complications every year.17 In many cases, life-threatening complications may be th ...
... NSAID usage occurs in 11% of the US population, which increases the odds of gastrointestinal bleeding five- to six-fold compared with those not taking NSAIDs.15,16 Some 1%–4% of NSAID users have serious ulcer-related complications every year.17 In many cases, life-threatening complications may be th ...
From, Dr. Swathi V Post Graduate in Department of Microbiology
... morbidity and mortality in these patients. Inappropriate and inadequate antibiotic treatment will lead to emergence of drug resistant pathogens and poor prognosis in patients on ventilator.1,2 ...
... morbidity and mortality in these patients. Inappropriate and inadequate antibiotic treatment will lead to emergence of drug resistant pathogens and poor prognosis in patients on ventilator.1,2 ...
The Patient with Asthma in the Emergency Department
... asthma exacerbation, there is an almost 20-fold increase in likelihood this will be required again [4]. Although older case-control studies using retrospectively collected data suggest that excess use of short-acting beta-agonists (SABA) was a risk factor, more recent information suggests that patte ...
... asthma exacerbation, there is an almost 20-fold increase in likelihood this will be required again [4]. Although older case-control studies using retrospectively collected data suggest that excess use of short-acting beta-agonists (SABA) was a risk factor, more recent information suggests that patte ...
Duopa®, carbidopa/levodopa enteral infusion, dru403
... This Medication Policy has been developed through consideration of medical necessity, generally accepted standards of medical practice, and review of medical literature and ...
... This Medication Policy has been developed through consideration of medical necessity, generally accepted standards of medical practice, and review of medical literature and ...
PDF - Journal of Population Therapeutics and Clinical
... sub-epidermal and it is accompanied with overlying epidermal necrosis.5,6 In both cases the re-growth of epidermis may begin, if there is no skin infection, within days but usually takes about three weeks.3 SJS and TEN are considered severe cutaneous drug reactions, but there is some evidence that o ...
... sub-epidermal and it is accompanied with overlying epidermal necrosis.5,6 In both cases the re-growth of epidermis may begin, if there is no skin infection, within days but usually takes about three weeks.3 SJS and TEN are considered severe cutaneous drug reactions, but there is some evidence that o ...
A retrospective study of 370 patients with oral lichen planus in Turkey
... higher mean age than those with white forms. In addition, white lesions presented a much greater male predominance while red lesions presented a much greater female predominance. These tendencies have been pointed out in a few studies (7,14). Location of the lesions within the oral cavity also showe ...
... higher mean age than those with white forms. In addition, white lesions presented a much greater male predominance while red lesions presented a much greater female predominance. These tendencies have been pointed out in a few studies (7,14). Location of the lesions within the oral cavity also showe ...
Uses of Carbamazepine for Psychiatric Disorders
... The drug's acute a n ti-ma nic e fficacy is a p p rox ima tely th at of chlorpromazine (18). In ov er half of treat ed patients, peak an ti man ic effects were reached within ten da ys of administrati on o f either ch lorp romazi ne or ca r bamazepine . Carbamazepine also lowered scores on th e Clin ...
... The drug's acute a n ti-ma nic e fficacy is a p p rox ima tely th at of chlorpromazine (18). In ov er half of treat ed patients, peak an ti man ic effects were reached within ten da ys of administrati on o f either ch lorp romazi ne or ca r bamazepine . Carbamazepine also lowered scores on th e Clin ...
PPT - American Academy of Pediatrics
... necessarily those of the American Academy of Pediatrics. Mead Johnson sponsors programs such as this to give healthcare professionals access to scientific and educational information provided by experts. The presenter has complete and independent control over the planning and content of the presen ...
... necessarily those of the American Academy of Pediatrics. Mead Johnson sponsors programs such as this to give healthcare professionals access to scientific and educational information provided by experts. The presenter has complete and independent control over the planning and content of the presen ...
ESOPHAGITIS: CAUSES Organisms (fungal)
... don’t know for sure But it is still more efficient to look for causes of regurgitation first ...
... don’t know for sure But it is still more efficient to look for causes of regurgitation first ...
Critical Analysis of Various Drugs Used for Thrombolytic Therapy in
... The Fibrinolysis Therapy Trialists (FTT) collaborators analysis demonstrated that thrombolysis was associated with an increase in stroke rate compared to control patients (1.2% versus 0.8%, P < 0.00001).28 An analysis from the GUSTO-1 Study demonstrated that the overall incidence of stroke following ...
... The Fibrinolysis Therapy Trialists (FTT) collaborators analysis demonstrated that thrombolysis was associated with an increase in stroke rate compared to control patients (1.2% versus 0.8%, P < 0.00001).28 An analysis from the GUSTO-1 Study demonstrated that the overall incidence of stroke following ...
Myxedema coma
... PATHOGENESIS — Myxedema coma can occur as the culmination of severe, long-standing hypothyroidism or be precipitated by an acute event such as infection, myocardial infarction, cold exposure, or the administration of sedative drugs, especially opioids. The demographics of patients who develop myxede ...
... PATHOGENESIS — Myxedema coma can occur as the culmination of severe, long-standing hypothyroidism or be precipitated by an acute event such as infection, myocardial infarction, cold exposure, or the administration of sedative drugs, especially opioids. The demographics of patients who develop myxede ...
Atrial Fibrillation
... Patients who present early (within 48 hours) who may be considered for very early cardioversion should be referred as an emergency, thus avoiding the need for a prolonged period of anti-coagulation before and after cardioversion. This includes younger patients not known to have structural heart dise ...
... Patients who present early (within 48 hours) who may be considered for very early cardioversion should be referred as an emergency, thus avoiding the need for a prolonged period of anti-coagulation before and after cardioversion. This includes younger patients not known to have structural heart dise ...
SERIES ‘‘RARE INTERSTITIAL LUNG DISEASES’’ Number 1 in this Series
... mesenchymal origin, containing smooth muscle, blood vessels and fat. The presence of fat in these lesions gives a characteristic CT appearance (fig. 2); diagnostic difficulty may arise in the small number of angiomyolipomas that do not contain fat. If the diagnosis of LAM is secure, these lesions ar ...
... mesenchymal origin, containing smooth muscle, blood vessels and fat. The presence of fat in these lesions gives a characteristic CT appearance (fig. 2); diagnostic difficulty may arise in the small number of angiomyolipomas that do not contain fat. If the diagnosis of LAM is secure, these lesions ar ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.